✦ LIBER ✦
Chiyoda goes on global offensive for next-generation ethylene plants
- Book ID
- 104385319
- Publisher
- Elsevier Science
- Year
- 2004
- Weight
- 34 KB
- Volume
- 2004
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
✦ Synopsis
Quest's ligand technology is being used by Pfizer for the process development and manufacture of new therapeutic compounds. The relationship covers a range of Chiral Quest's catalysts and ligands. This achievement further supports and develops Chiral Quest's goal of becoming a leading, high value technology provider of products and services to the chiral therapeutics industry.